Kallyope, Inc. — Form D
Kallyope, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-15. The offering totals $44.0M, of which $12.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-10-15
- Form: D
- Accession: 0001655846-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $44.0M
- Amount sold: $12.1M
- Remaining: $32.0M
- Investors: 8
- Date of first sale: 2015-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-249469
Issuer
- Name: Kallyope, Inc.
- CIK: 0001655846
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 430 EAST 29TH STREET, NEW YORK, NY, 10016
- Phone: 908-377-6454
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Adam Goulburn | Director | New York, NY |
| Adam Goulburn | Executive Officer | New York, NY |
| Michael O'Donnell | Executive Officer | Dallas, TX |
| Tim Kutzkey | Director | South San Francisco, CA |
| Kenneth Clark | Executive Officer | Miami, FL |
| William Rieflin | Director | South San Francisco, CA |
| Terry McGuire | Director | Waltham, MA |
| Joshua Wolfe | Director | Redmond, WA |
| Nancy Thornberry | Director | Boston, MA |
| Nancy Thornberry | Executive Officer | Boston, MA |
| Tom Maniatis | Director | New York, NY |
Other filings by this issuer (1)
More